有效的肺癌控制:癌症研究中的一个未完成的挑战
Neeraja Panakkal1,2, Asha Lekshmi1, Veena Vamadevan Saraswathy3
1Division of Cancer Research, Regional Cancer Centre, Thiruvananthapuram, Kerala, India.
CytoJournal
|September 8, 2023
概括
唾液细胞学为早期肺癌检测提供了一种有希望的非侵入性方法. 唾液分析的标准化和自动化是提高高风险个体的诊断准确性和风险评估的关键.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 生物标志物 生物标志物
背景情况:
- 由于晚期检测和低生存率,肺癌对社会造成了重大负担.
- 目前使用的成像方式如CT扫描,但早期检测仍然是一个挑战.
- 唾液细胞学正在被探索为早期肺癌诊断的不那么侵入性方法.
研究的目的:
- 审查唾液细胞学对早期肺癌检测的重要性.
- 在唾液样本中识别有效的生物标志物.
- 评估皮细胞学在高风险群体的风险评估中的潜力.
主要方法:
- 关于唾液细胞学和肺癌的已发表文章的审查.
- 讨论最近的唾液样本处理技术的进展.
- 对标准化和自动化的挑战和潜力的分析.
主要成果:
- 唾液细胞学显示了早期肺癌检测和风险评估的潜力.
- 样本处理方面的进步可以使诊断超越传统方法.
- 标准化和自动化对于常规应用和临床试验至关重要.
结论:
- 由现代技术增强的唾液细胞学对早期肺癌检测具有重大前景.
- 对于基于唾液的分子标记物,需要进一步标准化和验证加工技术.
- 优化唾液细胞学可以改善肺癌的诊断和管理,特别是在高风险人群中.
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


